Moat
Humana
Humana offers Medicare Advantage, stand-alone prescription drug plans, Medicaid and military health administration, senior primary care, pharmacy, and home health services.
Metadata
Where this company sits
- Ticker
- HUM
- Rank snapshot
- ≈ 263
- Sector
- Health Care
- Industry
- Managed Health Care
- Region
- United States
- Index
- S&P 500 · Top 275 by market cap
Metrics
Scoring view
Every metric is paired with a short rationale. The numbers are deliberate, not divine.
Decentralizability
4.0/10
Profitability
4.0/10
Price / Earnings
41.0x
Market cap
$46.1B
Freed-up capital potential
$4.6B
Narrative
Why the company matters
A short editorial overview plus the current thesis on moat strength and decentralization pressure.
Business Mix
Humana operates through Insurance and CenterWell, with the Insurance segment centered on Medicare Advantage, prescription drug plans, Medicare supplement, specialty benefits, Medicaid, and military health administration.
CenterWell extends the company into senior-focused primary care, home health, post-acute coordination, and pharmacy services, giving Humana a vertically integrated senior-care footprint rather than a pure insurance profile.
Financial Snapshot
StockAnalysis listed Humana at about $46.08 billion of market capitalization, $137.2 billion of trailing revenue, $1.13 billion of trailing net income, and a 41.02 P/E ratio at the June 26, 2026 close.
The financial profile is large but margin-thin: StockAnalysis showed TTM operating margin of about 1.78% and profit margin of about 0.83%, reflecting the pressure in managed care when medical costs rise faster than pricing or reimbursement.
Moat reading
Humana's moat is strongest in Medicare Advantage and senior care. It combines Medicare plan operations, provider networks, pharmacy and care-management workflows, risk adjustment expertise, brand recognition with seniors, and regulated relationships with CMS, states, the military health system, providers, brokers, and pharmacies.
The moat is durable because Medicare Advantage is operationally complex and capital-intensive, and because members, providers, claims data, plan design, Stars quality incentives, pharmacy fulfillment, and value-based primary care all reinforce one another. The weaker points are regulatory scrutiny, medical cost volatility, plan-rating changes, provider pushback, and interoperability rules that can make payer data less captive.
Decentralization reading
Humana is difficult to decentralize as a full insurer because Medicare Advantage and Medicaid managed care require licensed risk-bearing entities, actuarial capital, compliant benefit design, provider contracts, claims administration, utilization management, quality reporting, and government procurement.
The realistic decentralizing pressure is modular. Open health-financing software, payer FHIR APIs, patient-access and payer-to-payer data exchange, open EHR and practice-management tools, and provider or member cooperative governance can chip away at plan administration, care coordination, claims transparency, and clinic software lock-in without immediately replacing Humana's balance sheet or network scale.
Products
Where the moat actually touches users
These pages zoom into the products and services that matter most to each company, the alternatives already nibbling at them, and 2 structured disruption concepts across the current product set.
Medicare Advantage and prescription drug plans
1 conceptHumana Medicare Advantage plans are private Medicare Part C plans that offer Original Medicare Parts A and B coverage and commonly include prescription drug, dental, vision, hearing, preventive-care, and network-based care benefits.
Senior primary care, pharmacy, and home health
1 conceptCenterWell is Humana's senior-care services brand spanning senior-focused primary care, home health, post-acute coordination, and mail-order pharmacy services.
Technology waves
Strategic lenses
These are the repo's explicit bias terms: the technologies expected to keep making incumbents less inevitable over time.
Paper trail
Visible evidence trail
These sources shaped the scoring and writing. The site is opinionated, but it should not behave like it is improvising facts in a dark room.
Humana / U.S. Securities and Exchange Commission · annual report
Latest annual report for Humana's 2025 fiscal-year business, segment, risk, and financial context.
Reviewed 2026-06-27
StockAnalysis · market data
Market-data source for Humana's current market capitalization, P/E ratio, revenue, net income, stock price, and high-level profile snapshot.
Reviewed 2026-06-27
StockAnalysis · market data
Financial-data source for Humana's TTM and fiscal-year revenue, net income, operating margin, profit margin, and EPS context.
Reviewed 2026-06-27
StockAnalysis · market data
Company-profile source describing Humana's Insurance and CenterWell segments, business lines, founding information, and latest SEC filing links.
Reviewed 2026-06-27
CompaniesMarketCap · market data
Market-data source for Humana's June 2026 market capitalization and the registry's required CompaniesMarketCap URL.
Reviewed 2026-06-27
Humana · product page
Official Humana product page describing 2026 Medicare Advantage plan types, Part C coverage, supplemental benefits, and plan-search workflow.
Reviewed 2026-06-27
CenterWell · product page
Official CenterWell page describing senior-focused primary care, team-based care, virtual care, pharmacy links, and home-health links.
Reviewed 2026-06-27